Epigenetic Transgenerational Endocrine Disruptor Actions
表观遗传跨代内分泌干扰物作用
基本信息
- 批准号:8461236
- 负责人:
- 金额:$ 33.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAndrogensAnimalsBiological MarkersCell physiologyDNA MethylationDevelopmentDiagnosticDiseaseElementsEmbryoEndocrine DisruptorsEnvironmental ExposureEnvironmental HazardsEnvironmental Risk FactorEpidemiologyEpigenetic ProcessEtiologyExposure toGene ClusterGene Expression ProfileGenerationsGenesGerm CellsGerm LinesHealthHealth HazardsHuman DevelopmentImmuneIndividualIndustrial fungicideKidney DiseasesMale InfertilityMapsMethylationModelingMolecularOnset of illnessPathway interactionsPerinatal ExposurePesticidesPhenotypePhysiologicalPlasticsProstatic DiseasesRattusReproductionResearchRodentRoleSex DifferentiationSiteStagingSystemSystems BiologyTestingTissuesVariantbisulfitebody systemcohortdesigndisease phenotypeepigenetic markerepigenomefetalgenome-wideinsightmalenovelpyrosequencingsex determinationsperm celltransmission processtumorvinclozolin
项目摘要
DESCRIPTION (provided by applicant): Transgenerational effects of environmental factors, such as pesticides, plastics and fungicides, significantly amplify the impact and health hazards of these compounds. The transgenerational actions of these compounds require a heritable epigenetic alteration of the germline. This transgenerational epigenetic phenomenon is anticipated to be an important aspect of adult onset disease etiology, and suggests ancestral environmental exposure may influence disease epidemiology. The current proposal is designed to investigate this transgenerational phenomenon and the underlying epigenetic mechanism(s) involved. The model endocrine disruptor utilized will be the fungicide vinclozolin, an anti-androgenic compound, studied in an outbred rodent (i.e. rat) system. Previously, we demonstrated that vinclozolin exposure during embryonic gonadal sex determination promotes an epigenetic reprogramming of the male germline that then induces transgenerational adult onset disease states of male infertility, prostate disease, kidney disease, immune abnormalities and tumor development. The objective of the current proposal is to provide further insights into the molecular, cellular and physiological (i.e. systems biology) actions of this endocrine disruptor on the induction of this transgenerational epigenetic phenomenon. The overall hypothesis to be tested is that transient in utero exposure to the endocrine disruptor vinclozolin promotes a permanent reprogramming of the epigenome (i.e. DNA methylation) of the male germ line that then, through alterations in critical epigenetic regulatory mechanism(s), transgenerationally promotes adult onset disease (e.g. male infertility). Previous studies have shown a transgenerational epigenetic effect on the male germ line (sperm) through alterations in DNA methylation. This epigenetic alteration in the germ line is proposed to subsequently promote transgenerational effects on the epigenomes and transcriptomes of numerous organ systems in the adult. The current proposal is designed to further investigate these transgenerational epigenetic effects on the male germ line to determine the functional relationship with the induction of specific adult onset disease states, and to reveal the underlying epigenetic mechanisms responsible for this phenomenon. The experimental approach to test the above hypothesis consists of the following specific aims: 1) Investigate the transgenerational actions of vinclozolin on the sperm epigenome (DNA methylation) to identify genome-wide epigenetic biomarkers. 2) Characterize the direct and transgenerational effects of vinclozolin exposure on the fetal male germ cell epigenome and transcriptome. 3) Correlate the sperm epigenetic biomarkers with transgenerational adult onset disease phenotypes, and investigate the potential role of the biomarkers in the dysregulation of adult somatic tissue transcriptomes associated with specific disease states. Completion of the proposed research will determine how environmental exposures and compounds may promote adult onset disease in a transgenerational manner. The epigenetic biomarkers associated with the epigenetic reprogramming of the male germ line will be identified. The potential role these biomarkers may have in newly created epigenetic control regions (ECR) to promote transgenerational dysregulation of tissue transcriptomes will be established and provide insight into the etiology of adult onset disease. The potential for epigenetic biomarkers to be used as early stage diagnostic markers for specific adult onset disease states will also be established. The proposed research will more thoroughly investigate this epigenetic transgenerational phenomenon and elucidate the molecular mechanisms involved.
描述(由申请人提供):杀虫剂、塑料和杀菌剂等环境因素的跨代影响显着放大了这些化合物的影响和健康危害。这些化合物的跨代作用需要种系的可遗传的表观遗传改变。这种跨代表观遗传现象预计将成为成人发病疾病病因学的一个重要方面,并表明祖先的环境暴露可能会影响疾病流行病学。目前的提案旨在研究这种跨代现象以及所涉及的潜在表观遗传机制。使用的内分泌干扰物模型是杀菌剂乙烯菌核利,一种抗雄激素化合物,在近交啮齿动物(即大鼠)系统中进行了研究。此前,我们证明在胚胎性腺性别决定过程中暴露于乙烯菌核利会促进雄性种系的表观遗传重编程,从而诱导男性不育、前列腺疾病、肾脏疾病、免疫异常和肿瘤发展等跨代成年发病疾病状态。当前提案的目的是进一步了解这种内分泌干扰物对诱导这种跨代表观遗传现象的分子、细胞和生理(即系统生物学)作用。待测试的总体假设是,子宫内短暂暴露于内分泌干扰物乙烯菌核利会促进男性种系表观基因组(即 DNA 甲基化)的永久性重编程,然后通过关键表观遗传调控机制的改变,跨代促进成年发病(例如男性不育)。先前的研究表明,通过 DNA 甲基化的改变,对雄性种系(精子)产生跨代表观遗传效应。种系中的这种表观遗传改变被认为随后会促进对成人许多器官系统的表观基因组和转录组的跨代影响。目前的提案旨在进一步研究这些对雄性种系的跨代表观遗传效应,以确定与诱导特定成人发病疾病状态的功能关系,并揭示导致这种现象的潜在表观遗传机制。检验上述假设的实验方法包括以下具体目标:1)研究乙烯菌核利对精子表观基因组(DNA 甲基化)的跨代作用,以确定全基因组表观遗传生物标志物。 2) 表征乙烯菌核暴露对胎儿男性生殖细胞表观基因组和转录组的直接和跨代影响。 3)将精子表观遗传生物标志物与跨代成人发病表型相关联,并研究生物标志物在与特定疾病状态相关的成人体细胞组织转录组失调中的潜在作用。完成拟议的研究将确定环境暴露和化合物如何以跨代方式促进成人发病。将鉴定与雄性种系的表观遗传重编程相关的表观遗传生物标志物。这些生物标志物在新创建的表观遗传控制区(ECR)中可能具有促进组织转录组跨代失调的潜在作用,这将有助于深入了解成人发病的疾病的病因学。表观遗传生物标记物用作特定成人发病疾病状态的早期诊断标记物的潜力也将被确定。拟议的研究将更彻底地研究这种表观遗传跨代现象并阐明所涉及的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL K SKINNER其他文献
MICHAEL K SKINNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL K SKINNER', 18)}}的其他基金
Epigenetic Transgenerational Endocrine Disruptor Actions
表观遗传跨代内分泌干扰物作用
- 批准号:
8696510 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONS
表观遗传跨代内分泌干扰作用
- 批准号:
7434209 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
Epigenetic Transgenerational Endocrine Disruptor Actions
表观遗传跨代内分泌干扰物作用
- 批准号:
9247187 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
Epigenetic Transgenerational Endocrine Disruptor Actions
表观遗传跨代内分泌干扰物作用
- 批准号:
8845554 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
相似海外基金
Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
- 批准号:
10930196 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
- 批准号:
10735807 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
- 批准号:
RGPIN-2019-04999 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Discovery Grants Program - Individual
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
- 批准号:
10418461 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10570208 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10355174 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10688086 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
- 批准号:
2744296 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Studentship
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10431620 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10525097 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:














{{item.name}}会员




